Cells govern biological functions through complex biological networks. Perturbations to networks may drive cells to new phenotypic states, for example, tumorigenesis. Identifying how genetic lesions perturb molecular networks is a fundamental challenge. This study used large-scale human interactome data to systematically explore the relationship among network topology, somatic mutation, evolutionary rate, and evolutionary origin of cancer genes. We found the unique network centrality of cancer proteins, which is largely independent of gene essentiality. Cancer genes likely have experienced a lower evolutionary rate and stronger purifying selection than those of noncancer, Mendelian disease, and orphan disease genes. Cancer proteins tend to have ancient histories, likely originated in early metazoan, although they are younger than proteins encoded by Mendelian disease genes, orphan disease genes, and essential genes. We found that the protein evolutionary origin (age) positively correlates with protein connectivity in the human interactome. Furthermore, we investigated the network-attacking perturbations due to somatic mutations identified from 3,268 tumors across 12 cancer types in The Cancer Genome Atlas. We observed a positive correlation between protein connectivity and the number of nonsynonymous somatic mutations, whereas a weaker or insignificant correlation between protein connectivity and the number of synonymous somatic mutations. These observations suggest that somatic mutational network-attacking perturbations to hub genes play an important role in tumor emergence and evolution. Collectively, this work has broad biomedical implications for both basic cancer biology and the development of personalized cancer therapy.
Introduction
Tumorigenesis is often initiated by driver gene mutations that directly or indirectly confer a selective growth advantage to the cell (Vogelstein et al. 2013) . A typical tumor contains two to eight driver gene mutations (Kandoth et al. 2013; Vogelstein et al. 2013) . The majority of the remaining somatic mutations are passenger mutations that have no direct or indirect effects on cell's growth rate (Vogelstein et al. 2013 ). The findings from recent comprehensive sequencing of human tumors, for example, The Cancer Genome Atlas (TCGA) project, support the view that cancer cells express a mutator phenotype (Loeb 2011) . However, understanding the transition from a normal cell to a tumor cell as initiated by genetic lesions is a challenge in cancer biology.
Cells contain a vast array of molecular structures that form complex, dynamic, and flexible biological networks (Pe'er and Hacohen 2011). Perturbation(s) to human molecular networks, termed "cancer network attractors," may drive cells to new phenotypic states, for example, tumorigenesis (Wang et al. 2007; Creixell et al. 2012) . Identifying how genetic lesions, for example, somatic mutations, perturb these networks will increase our understanding of the genotype-to-phenotype relationship during tumorigenesis. The traditional strategy of studying a single gene or protein in isolation limits the ability to derive a comprehensive catalogue of cellular mechanisms. In contrast, network biology provides a deeper understanding of the processes by which genetic lesions perturb the network topology and result in diseases (Creixell et al. 2012) . Goh et al. (2007) found that a large number of Mendelian disease genes (MDGs) are nonessential and do not tend to encode hub proteins. Zhang et al. (2011) found that the majority of orphan disease-causing mutant genes (ODMGs) are essential, and they are topologically important in human interactome and are ubiquitously expressed. Additionally, understanding the relationship between evolution and network topology of cancer genes is critical to decipher the process of mutations and the cellular network perturbations of the human genome (Kumar et al. 2011 Dudley et al. 2012 ). Dickerson and Robertson (2012) studied the origins of MDGs in human and found that the evolution of new genes (de novo or by duplication) may have the susceptibility to the emergence of new diseases. However, our understanding of the network topological characteristics and evolutionary trajectories of cancer genes and their somatic mutations has been remarkably limited compared with the studies of MDGs and ODMGs.
In this study, we investigated the relationship among network topology, evolutionary rate, and evolutionary origin of disease-driven somatic and germline mutations in the context of the protein-protein interaction (PPI) networks, using recently released massive somatic mutation and gene annotation data. We focused on two questions: 1) Do cancer genes occupy more critical network topological positions than MDGs and ODMGs and have different evolutionary trajectories? and 2) from a network biology perspective, how does the transition occur from a normal cell to a tumor cell as initiated by genetic lesions? We found distinct network and evolutionary signatures of cancer proteins. Cancer proteins tend to occupy central hubs in the human interactome, regardless of whether they are essential or nonessential proteins. Cancer proteins tend to have ancient histories, although they are younger than proteins encoded by MDGs, ODMGs, and essential genes. Moreover, protein evolutionary origin (age) positively correlates with protein connectivity in the human interactome. There has been a hypothesis that network-attacking perturbations due to somatic mutations primarily occur in the central hub genes of the cancer interactome. Our analyses using the largest ever somatic mutation data supported this hypothesis. Thus, this work increases our understanding of the roles of somatic mutational network-attacking perturbations in tumorigenesis and has broad biomedical implications for both basic cancer research and the development of personalized cancer therapy.
Results

Cancer Protein Interactome
We compiled a comprehensive set of cancer genes from three high-quality data sources: CancerGenes (CG) (Higgins et al. 2007 ), Network of Cancer Genes (NCG) (D'Antonio et al. 2012) , and Cancer Gene Census (CGC) (Forbes et al. 2011) . Genes collected from these resources were well-curated from literatures by database curators or experimentally validated. We combined these cancer genes into the Catalog of Cancer Genes (CCGs), which contains a total of 4,050 cancer genes with network information and functional annotations (supplementary table S1, Supplementary Material online). Among the 4,050 CCGs, 349 (8.6%) are oncogenes, 808 (20.0%) are tumor suppressor genes (TSGs), and 129 (3.2%) are both oncogenes and TSGs ( fig. 1A) . Considering that the current publicly available human protein interactomes are still incomplete, we constructed five different yet complementary human protein interactomes: A physical PPI network (PPIN) (Cowley et al. 2012; Breuer et al. 2013) , an atomic resolution three-dimensional structural PPIN (3DPPIN) (Meyer et al. 2013 ), a kinase-substrate interaction network (KSIN) (Keshava Prasad et al. 2009; Dinkel et al. 2011; Hornbeck et al. 2012; Newman et al. 2013) , an innate immunity PPIN (INPPIN) (Breuer et al. 2013) , and a large computationally predicted PPIN (CPPIN) (Lee et al. 2011 ) (supplementary  table S2 , Supplementary Material online). Each of the first four networks represents a specific biological perspective. The fifth one (CPPIN) is constructed using a naïve Bayes approach to weight different types of evidence into a single interaction score and contains data from humans, yeasts, worms, and flies (Lee et al. 2011) . The collection of these five protein interactomes and their corresponding disease gene sets are available at http://bioinfo.mc.vanderbilt.edu/ CCG/ (last accessed July 1, 2013). To evaluate the quality of these networks, we investigated the distribution of gene coexpression correlations in each network. The Pearson correlation coefficient (PCC) of each gene coexpression pair was calculated from the microarray gene expression data of 126 human normal tissues (Benita et al. 2010) . We found that the five networks are more enriched with large PCC values than the random gene coexpression network ( fig. 1B) and that 3DPPIN has the strongest enrichment in high PCC values.
Next, we constructed a comprehensive cancer protein interactome by mapping the 4,050 CCG proteins onto the above four human protein interactomes; CPPIN was excluded because it was from computational predictions. A total of 3,650 CCG proteins (90.1%) were successfully mapped with at least one interaction, and 10,773 of these interacting partners were recruited. Overall, the final cancer protein interactome includes 95,578 unique interactions: 79,755 physical PPI pairs, 3,487 three-dimensional structural PPI (3DPPI) pairs, 7,226 kinase-substrate interaction (KSI) pairs, and 5,110 innate immunity PPI (INPPI) pairs ( fig. 1C ). In this network, nodes denote proteins and edges denote interactions. Specifically, edges indicate one or more of the four types of protein interaction pairs (i.e., physical PPI, 3DPPI, KSI, and INPPI). To investigate the cancer protein network topology, we calculated node connectivity (the number of interacting partners). As expected, cancer proteins tend to have a higher connectivity than that of noncancer proteins. More specifically, the overall connectivity of TSG, oncogenes, and the remaining cancer proteins is higher than those for other proteins ( fig. 1C ). The top five proteins are UBC, HNF4A, ELAVL1, SUMO2, and CUL3. This comprehensive cancer protein interactome provides a valuable resource for cancer gene functional and network analysis.
Unique Network Centrality of Cancer Proteins
The network approach is useful for exploring the biological function of genes. For example, the highly connected nodes (genes or proteins) in the network, namely hubs, tend to be essential for basic cellular activities (He and Zhang 2006; Goh et al. 2007; Feldman et al. 2008; Zhang et al. 2011) . To examine network topology of different gene sets, we defined "hubs" as those nodes that were ranked at the top 20% of the connectivity distribution according to previous studies (Yu et al. 2007; Zhang et al. 2011 We further explored different types of disease genes for their essentiality in humans. Essential genes are defined as those genes whose knockouts lead to inviability or infertility. The comparison between essential genes and our CCGs revealed a significant enrichment of CCGs in essential genes (P < 2.2 Â 10 À200 ; fig 
À138
; fig. 2C ) are essential genes. Collectively, all three types of disease (cancer, Mendelian disease, and orphan disease) genes are significantly enriched with essential genes. As essential proteins are more likely to be hubs (Goh et al. 2007 ), we divided each of the three disease protein types (CCG, MDG, and ODMG) into essential and nonessential disease proteins, resulting in six subgroups ( fig. 2) . We then examined the enrichment of these subgroups with hubs in the five protein interactomes (supplementary tables S6-S10, Supplementary Material online). Both essential and nonessential cancer proteins showed a strong tendency toward hubs in PPIN (essential cancer proteins: P = 9.8 Â 10
À212
, nonessential cancer proteins: P = 3.7 Â 10
À43
; fig fig. 2A) . Surprisingly, when we removed the cancer proteins from the essential proteins, the remaining essential proteins (noncancer essential proteins) were not enriched in hubs in PPIN, 3DPPIN, KSIN, or INPPIN (odds ratio < 1; fig. 2A and supplementary tables S6-S10, Supplementary Material online). Furthermore, 122 of the 125 cancer driver genes in a previous work (Vogelstein et al. 2013 ) could be mapped onto PPIN and 100 of them were hubs (P = 6.2 Â 10
À50
; supplementary fig. S3A , Supplementary Material online). Moreover, proteins encoded by cancer driver genes tended to have a stronger enrichment of hubs in PPIN than by nondriver cancer genes (P = 2.0 Â 10 À26 ), suggesting that cancer driver genes are more functionally important in the protein interactome. Collectively, cancer proteins display a unique network centrality (i.e., hubs), compared with Mendelian or orphan disease proteins, and this centrality is largely independent of gene essentiality.
Selective Pressure and Evolutionary Rate of Cancer Genes
We examined selective pressure on all disease genes by computing their nonsynonymous and synonymous substitution rate ratio (the dN/dS ratio) using human-mouse orthologous genes, including 3,775 CCGs, 2,534 MDGs, and 2,004 ODMGs (supplementary table S11, Supplementary Material online). A dN/dS ratio of 1 implies neutral evolution, a ratio below 1 implies purifying selection, and a ratio above 1 implies positive Darwinian selection (Hirsh et al. 2005 ). Approximately, 50% disease genes had the dN/dS ratio smaller than 0.1 ( fig. 3A) . Accordingly, we divided disease genes into two groups: The low dN/dS ratio group (<0.1) and the high dN/dS ratio group (!0.1). We found that CCGs tended to be under stronger purifying selection (i.e., more likely to be in the low dN/dS ratio group; P = 4.1 Â 10 À46 , Fisher's exact test; fig. 3C ). MDGs and ODMGs are also more likely to be in the low dN/dS ratio group (P = 1.2 Â 10 À3 and 2.0 Â 10 À5 , respectively; fig. 3C ). However, CCGs are more significantly enriched with a low dN/dS ratio (<0.1) than MDGs (P = 8.3 Â 10 À8 ) or ODMGs (P = 4.0 Â 10
À4
). In addition, we reexamined the evolutionary rate ratio (Bezginov et al. 2013) , using the criterion that a ratio >1 indicates a fast rate and a ratio <1 indicates a slow rate. The overall evolutionary rate ratio of CCGs was significantly lower than that of MDGs (P = 3.2 Â 10
À9
) and that of ODMGs (P = 2.2 Â 10 À15 ), consistent with the dN/dS ratio observations ( fig. 3B ).
We further examined the selective pressure of the essential disease genes. Both essential and nonessential cancer genes (P = 2.7 Â 10 À28 and 3.7 Â 10
À17
) tend to have a low dN/dS ratio. In contrast, nonessential MDGs and nonessential ODMGs do not show such a strong trend (P = 0.11 and 0.04; supplementary table S12, Supplementary Material online). The average dN/dS ratio of CCGs is 0.12, which is significantly lower than the average dN/dS ratio (0.16) of the noncancer genes (P = 2.0 Â 10 À59 , Wilcoxon test; fig. 3D ). Moreover, the average evolutionary rate ratio of CCGs is 0.97, significantly lower than the average evolutionary rate ratio (1.36) of the noncancer genes (P = 9.9 Â 10
À116
; fig. 3E ). Among the 125 cancer driver genes, 79 displayed a stronger tendency of low dN/dS ratios (P = 9.5 Â 10 It is known that highly connected genes tend to be essential genes (He and Zhang 2006) and have lower dN/dS ratios (Han et al. 2013) . Thus, the evolutionary conservation of cancer genes is consistent with their unique network centrality in the human protein interactome. Proportion of genes with a low dN/dS ratio (<0.1, solid bars) and with a high dN/dS ratio (!0.1, striped bars). The P values were calculated by Fisher's exact test. In (D) and (E), the box plots showing the distribution of the dN/dS ratio (D) and the evolutionary rate ratio (E) for noncancer genes, CGC, and CCG. The P values were calculated by the Wilcoxon test.
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Evolutionary Origins of Cancer Proteins
The evolutionary history of a protein might reflect its functional evolution. We estimated the evolutionary origin (also known as divergence time or protein age) of disease proteins using a phylogenetic approach implemented by ProteinHistorian (Capra et al. 2012) . The average divergence time (Jaccard clustering) of 3,891 CCG proteins was 1,248.5 AE 15.7 Ma. This observation seems to suggest that cancer proteins tend to be ancient proteins (Srivastava et al. 2010 ). However, the average divergence time (OrthoMCL clustering) of CCG proteins was significantly younger than that of the ODMG proteins (1,564.0 AE 30.2 Ma, P = 1.4 Â 10 À6 , Wilcoxon test) or that of the essential proteins (1,487.8 AE 24.8 Ma, P = 4.0 Â 10 À7 ) ( fig. 4A ). The CGC genes are well-curated and have been widely used as a reference cancer gene set in many cancer-related projects (Jia and Zhao 2014) . The averaged divergence time (1,098.2 AE 45.1 Ma, Jaccard clustering) of CGC proteins was younger than that of the CCG proteins, and also younger than that of the MDG proteins (1,379.9 AE 24.4 Ma, P = 5.1 Â 10 À5 ), the ODMG proteins (1,415.4 AE 28.0 Ma, P = 4.5 Â 10 À6 ), and the essential proteins (1,411.5 AE 21.8 Ma, P = 7.4 Â 10 À12 ) ( fig. 4B ). Collectively, cancer proteins tend to have ancient histories (likely originated in early metazoan according to the estimated ages above), although they are younger than proteins encoded by MDGs, ODMGs, and essential genes. Dickerson and Robertson (2012) found that the evolutionary origins of heritable genetic disease genes have a tendency to be ancient, coming into existence with early metazoans. Srivastava et al. (2010) found that genes in sponges (600 Ma) tend to be categorized as cancer genes. Our analyses based on the largest ever collection of disease genes provided additional evidence.
Network Evolution of Cancer Proteins
We explored the relationship between network topology and evolutionary origin of proteins, by calculating the correlation using a linear regression fit between protein connectivity and their origins. A positive correlation was observed between the protein connectivity in all three networks and their protein origins calculated by the Jaccard clustering approach: Pearson's r = 0.98 (P = 1.9 Â 10 À4 , F statistics; fig. 5A ) in 3DPPIN, r = 0.95 (P = 8.3 Â 10
À4
; fig. 5C ) in PPIN, and r = 0.72 (P = 0.066; fig. 5E ) in CPPIN. Similarly, a significantly positive correlation was observed when using the OrtholoMCL clustering approach to compute protein origins ( fig. 5B, D, and F) . Additionally, a slightly positive correlation between the protein connectivity in KSIN and INPPIN with their protein origins was observed (supplementary fig. S4 , Supplementary Material online). We repeated the analyses using an independent measurement of protein origins, that is, the evolutionary distance from the human protein sequence to the orthologous groups (Bezginov et al. 2013 ). Again, a positive correlation was observed between the protein connectivity and their evolutionary distance (supplementary fig. S5 , Supplementary Material online). Put together, the protein evolutionary origin plays an important role in the cancer protein network evolution.
Somatic Mutational Network-Attacking Perturbations on the Cancer Interactome
We collected the massive high-quality somatic mutation profiles in 3,268 tumors across 12 cancer types from TCGA. In total, 450,838 nonsynonymous somatic mutations, including 433,117 single nucleotide variants and 17,721 short insertions and deletions (indels), in the 18,242 protein-coding gene regions from TCGA were investigated. We grouped data into bins based on the protein ages calculated using OrthoMCL clustering method, and used these binned data for a linear regression fit analysis. For proteins harboring nonsynonymous somatic mutations, we found a positive correlation of protein connectivity in PPIN with the number of nonsynonymous somatic mutations in all 12 cancer types (Pearson's r = 0.81, P = 1.2 Â 10
À4
; fig. 6A ). In addition, we collected large-scale somatic mutation profiles from the Catalogue of Somatic Mutations in Cancer (COSMIC) database; this collection included 848,455 nonsynonymous single nucleotide variants 
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Tumorigenesis due to Somatic Mutational Network-Attacking Perturbations . doi:10.1093/molbev/msu167 MBE most of somatic mutations are expected to be passenger mutations, as a comparison, we investigated the correlation of the protein connectivity with synonymous mutations. We collected 129,150 synonymous mutations in 17,337 genes from TCGA. We did not find a significant correlation (r = 0.49, P = 0.06; supplementary fig. S7A , Supplementary Material online) with cancer proteins' synonymous mutations. However, when we examined all proteins (supplementary table S15, Supplementary Material online), we observed a positive correlation (r = 0.65, P = 6.9 Â 10 À3 ; supplementary fig. S7B, Supplementary Material online) . Thus, the correlation using synonymous mutations was weaker than that of the nonsynonymous somatic mutations using the binned data ( fig. 6 and supplementary fig. S7 , Supplementary Material online). In order to examine the bias of the linear regression fit analysis using the binned data, we recalculated the correlation between the protein connectivity and the number of somatic mutations using the unbinned data. As in the binned data analysis, we found a significantly positive correlation between protein connectivity and the number of nonsynonymous somatic mutations using the unbinned data in TCGA (P = 1.2 Â 10
À8
) and COSMIC (P = 8.9 Â 10 À22 ; supplementary fig. S8, Supplementary Material online) . However, we did not observe a significant correlation between protein connectivity and the number of synonymous somatic mutations using the unbinned data (P = 0.19; Supplementary fig. S8 , Supplementary Material online). As the synonymous substitutions do not alter protein sequences, this finding supports that most synonymous substitutions are simply not positively selected in cancer genes. Interestingly, recent studies showed that the synonymous mutations might affect protein evolution by influencing the transcription factor binding sites (Stergachis et al. 2013) or splicing sites (Supek et al. 2014) . However, such mutations account for a small portion of the . We grouped data into bins based on the protein ages calculated using the OrthoMCL clustering method, and used these binned data for the linear regression fit analyses. The red error bars denote the standard error of the mean (SEM) for the number of nonsynonymous somatic mutations. The blue error bars denote the SEM for the protein connectivity. The green error bars denote the SEM for the gene avePCC. The data are provided in supplementary tables S14 and S15, Supplementary Material online. The linear regression fit analyses using the unbinned data are provided in supplementary fig. S8 , Supplementary Material online.
synonymous somatic mutations in cancer genomes, and our current analyses could not effectively detect the specific selective constraint on transcription factor binding sites and splicing sites. In future studies, we may separate synonymous somatic mutations into groups by their potential functions and compare their network characteristics. Collectively, these findings support the notion that somatic mutational network-attacking perturbations on central hubs of the cancer protein interactome play important roles in tumorigenesis.
We further investigated how somatic mutational perturbations influence the gene coexpression network. As it takes two genes to derive a PCC value, we calculated the gene average coexpression coefficient (avePCC) for each gene using ð Þ i ¼ P j PCC ij between gene i and gene j (j belongs to the set of gene i's interacting partners in PPIN). We used the microarray expression data of 126 normal tissues (see Materials and Methods). We then calculated the correlation between the gene avePCC and the number of nonsynonymous somatic mutations (supplementary table S17, Supplementary Material online) and found r = À0.60 (P = 0.014; fig. 6C ) for TCGA and r = À0.65 (P = 6.6 Â 10 À3 ; fig. 6D ) for the COSMIC database. Supplementary fig. S9 , Supplementary Material online, showed that hub genes often tend to heterogeneously coexpress (low avePCC value) with their interacting partners in PPIN. Thus, the negative correlation between the gene avePCC and the number of nonsynonymous somatic mutations is consistent with the positive correlation between the protein connectivity and the number of nonsynonymous somatic mutations. Overall, these observations further support the concept of somatic mutational network-attacking perturbations during tumor emergence and evolution.
Network Evolution of Cancer Cell Metabolism Genes
We noted that the correlation between protein connectivity and protein evolutionary origin was much weaker in four of the five networks when the most ancient proteins were included (supplementary fig. S10A -H, Supplementary Material online). For example, there was no correlation between protein connectivity and protein evolutionary origin when the most ancient genes were included in 3DPPIN (supplementary fig. S10E and F, Supplementary Material online). When the most ancient genes (4,200 Ma) were excluded, a strikingly high positive correlation (r = 0.98, P = 1.9 Â 10 À4 , fig. 5A ) was observed in 3DPPIN. A similar trend was observed in PPIN. This finding implies that the network growth of protein connectivity follows two distinct network evolutionary models. For nonancient proteins (protein age younger than 1,600 Ma), the protein connectivity increased by divergence time. However, the growth of protein connectivity of the most ancient proteins (older than 1,600 Ma) was slow. For CPPIN, we found a high correlation between protein connectivity and protein evolutionary origin when the most ancient genes were included. One possible reason is that CPPIN contains a large number of ancient PPIs that were collected from yeasts, worms, and flies (Lee et al. 2011 ). The cutoff age of 1,600 Ma happens to be the transition time between Paleoproterozoic and Mesoproterozic, when aerobic respiration began to emerge (Zhao et al. 2004 ). To interpret these findings, we identified the 282 most ancient cancer genes (4,200 Ma) and conducted a Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis using ClueGO (Bindea et al. 2009 ). We found most of these ancient cancer genes enriched in cell metabolism and DNA repairrelated pathways (supplementary table S17 . For instance, the connectivity of two most ancient proteins, IDH1 and IDH2 (4,200 Ma), in PPIN is only 3 and 5, respectively; however, we found as many as 21 and 16 nonsynonymous somatic mutations in IDH1 and IDH2 across 12 cancer types in TCGA. Several recent works reported that IDH1 and IDH2 are cancer driver genes that involve the cellular differentiation of glioma cells (Rohle et al. 2013 ) and leukemia cells . Based on the notion of Weinberg's effect, cancer cell metabolism is a hallmark of cancer (Hanahan and Weinberg 2011) . Thus, the transition between aerobic respiration and anaerobic respiration may result in unusual mutagenic events on cancer genes. Therefore, the somatic mutational perturbations on the cancer cell metabolism genes complement our evolutionary model of cancer gene network.
Discussion
The notion of somatic mutational network-attacking perturbations on the cancer interactome, such as cancer network attractors (Creixell et al. 2012 ) and mutator phenotype (Loeb 2011) , has attracted much attention. To address this important issue, we systematically investigated the relationship among network topology, somatic mutation, evolutionary rate, and evolutionary origin of cancer genes in the largecontext human interactome data. We found the unique network centrality of cancer proteins, which is largely independent of gene essentiality. The unique network centrality of cancer genes is consistent with their high evolutionary conservation. Furthermore, we examined the network-attacking perturbations through somatic mutations identified from 2165 Tumorigenesis due to Somatic Mutational Network-Attacking Perturbations . doi:10.1093/molbev/msu167 MBE over 3,000 tumors across 12 cancer types from TCGA. We found a significantly positive correlation between protein connectivity and the number of nonsynonymous somatic mutations, whereas a weaker or insignificant correlation between protein connectivity and the number of synonymous somatic mutations. Collectively, these observations support the view that somatic network-attacking perturbations on hub genes play an important role in tumor emergence and evolution.
In 1976, Nowell published a landmark perspective on cancer as an evolutionary process. Our network evolutionary model differs from the concept of clonal genome evolution in cancer. The tumor clonal evolution takes place within tissue ecosystem habitats, which have evolved for over a billion years to optimize multicellular function but restrain the clonal expansion of renegade cells (Greaves and Maley 2012; Aparicio and Caldas 2013) . The pinnacle of the somatic adaptation process, for example, tumor cells, acquires the ability to proliferate autonomously while escaping selective pressures exerted by microenvironmental interactions within tissue ecosystems (Podlaha et al. 2012) . Therefore, evolutionary trajectories of organisms, in a similar fashion to evolution of tumors, take place through competition for space and resources (e.g., nutrition). Here, we found the unique network centrality of cancer proteins in comparison to Mendelian and orphan disease proteins. Although essential proteins often encode hub proteins, nonessential cancer proteins may also encode hubs. This observation suggests that cancer protein network centrality is largely independent of gene essentiality. However, nonessential Mendelian and orphan disease proteins did not tend to be central hubs. Goh et al. (2007) explained the unexpected network peripherality of Mendelian disease proteins using an evolutionary argument. Because mutations on hub proteins are more likely to create a severe impairment of normal developmental and/or physiological function, they generate lethality in utero or early extrauterine life, leading to eventual elimination from the population. Thus, heritable disease-driven germline mutations in the peripheral regions of the cellular network produce a higher change in viability (Goh et al. 2007) . In this study, we found the unique network centrality (e.g., hubs) of cancer genes, which fits well with the above evolutionary argument.
In this study, we observed a positive correlation between protein connectivity and protein origin (age). Protein age plays an important role in the evolution of cancer protein network topological characteristics. Furthermore, we observed a significantly positive correlation between protein connectivity and the number of nonsynonymous somatic mutations. One possible reason for this correlation is that cancer genes are usually highly expressed (because they tend to be hubs and essential genes), so that they suffer high mutation rates (Park et al. 2012; Chen and Zhang 2013) . However, there are actually two cancer gene expression patterns. First, TSGs are usually highly expressed in normal tissues but not in tumor tissues due to "loss-of-function" by somatic mutations (Rahman 2014) . Second, oncogenes are usually highly expressed in tumor tissues due to "gain-of-function" by somatic mutations (Croce 2008; Rahman 2014 ).
However, we did not find a significant correlation between protein connectivity and the number of synonymous somatic mutations, consistent with the notion that synonymous mutations are usually neutral. In summary, cancer genes that are progressively acquired during evolution tend to encode hubs in the human protein interactome.
The unique network centrality and stronger evolutionary conservation of cancer genes in comparison to MDGs and ODMGs may explain the different epidemiological features between common diseases (e.g., cancer) and Mendelian diseases. Somatic mutations on hubs tend to cause stronger network perturbations than nonhub mutations and might be a major source of tumor driver mutations, contributing to cancer epidemics (Jemal et al. 2011) . Thus, cancer might be an inescapable disease. West et al. (2012) found that cancer cells are characterized by an increase in network entropy and Bashan et al. (2012) found that each physiological state is characterized by a specific network structure. Therefore, mutations on hubs would have stronger physiological consequences than mutations in the network periphery (Feldman et al. 2008) . Collectively, the observation of somatic mutational network-attacking perturbations to hub genes may explain the high biological efficiencies by a few driver mutations (Kandoth et al. 2013; Vogelstein et al. 2013 ). Due to the unique network centrality and the relatively younger evolutionary history of cancer proteins, the global burden of cancer may continue to increase as the average human longevity increases. A practical implication of our findings concerns biomedical research strategies. In view of our finding that cancer proteins with stronger evolutionary selective pressure are relatively young proteins, it seems that we should avoid using animal models that are distantly related to humans such as yeasts and nematodes.
Materials and Methods
Collection of Cancer-Associated Genes
We collected cancer genes from the following resources. First, 487 genes were downloaded from CGC (Futreal et al. 2004; Forbes et al. 2011 ) (http://cancer.sanger.ac.uk/cancergenome/ projects/census/, last accessed July 1, 2013) and are denoted as CGC genes. Next, 1,494 genes were collected from the NCG (D'Antonio et al. 2012) (v3.0; denoted as NCG). In comparison to CGC genes, NCG genes included more mutated genes from recent cancer whole exome and whole genome sequencing projects. Finally, more than 3,000 cancer-associated genes were collected from the CG database (Higgins et al. 2007) . The data in the CG database are mainly based on expert curation or annotation information from the main public databases. These resources provide overlapping and complementary candidate cancer genes. We took a union of the CGC genes, NCG genes, and CG to construct a comprehensive CCGs, including a total of 4,050 cancer genes (supplementary table S1, Supplementary Material online). Each gene has an Entrez ID and genomic coordinate based on the National Center for Biotechnology Information (NCBI) database (July 10, 2013) (Corrdinators 2013 ).
Other Disease-Associated Genes MDGs were downloaded from the Online Mendelian Inheritance in Man (OMIM) database (Hamosh et al. 2005) . As of December 2012, the OMIM contained 4,132 genedisease association pairs connecting 2,716 disease genes in 3,294 Mendelian diseases or disorders. After mapping them to the NCBI Entrez IDs, 2,714 genes were included in our study. In addition, we collected 2,124 ODMGs from a previously published work (Zhang et al. 2011 ). An orphan disease is defined by the US Rare Disease Act of 2002 as a rare disease that affects less than 200,000 inhabitants, equivalent to approximately 6.5 patients per 10,000 inhabitants (Dear et al. 2006 ).
Other Annotated Genes
The oncogenes and TSGs were annotated using information from two publicly available databases: CG (Higgins et al. 2007) and TSGene (Zhao et al. 2013) . Essential genes, whose knockouts result in inviability or infertility, are of a substantial importance in studying the robustness of a biological system and identifying effective drug targets. We collected 2,721 essential genes from the Online GEne Essentiality database ).
Compiling a High-Quality Binary PPIN
We downloaded human PPI data from two resources: The Protein Interaction Network Analysis (PINA) platform (Cowley et al. 2012) and InnateDB (Breuer et al. 2013) . PINA (v2.0) is a comprehensive PPI database that integrates six large-scale public databases. A total of 105,190 interactions were included in PINA as of May 1, 2013. We retrieved only those experimentally validated pairs with well-defined experimental protocol, resulting in a list of 97,658 unique interactions among 12,644 proteins. InnateDB contained more than 196,000 experimentally validated molecular interactions in human, mouse, and bovine models. In this study, an interaction is defined as high quality when it is labeled as experimentally validated on human through a well-defined experimental protocol. All interactions that did not satisfy this criterion were discarded. Throughout this work, we implemented two data cleaning steps. First, all protein-coding genes were annotated with an Entrez ID, chromosome location, and the gene symbol from the NCBI database. Second, duplicated or self-loop PPI pairs were removed. After data cleaning, we obtained a total of 113,473 unique PPI binary pairs connecting 13,579 proteins. The data are available at http://bioinfo.mc.vanderbilt.edu/CCG/ (last accessed July 1, 2014.
Three-Dimensional Structural PPIN
The three-dimensional structurally resolved PPI (3DPPI) pairs were collected from the Instruct database (Meyer et al. 2013 ). After removing self-loop pairs, we collected 4,278 unique 3DPPI pairs connecting 2,609 proteins in this 3DPPIN.
Kinase-Substrate Interaction Network
Considering kinase phosphorylation has been frequently involved in cancer, we collected KSI pairs from four databases: Phospho.ELM (Dinkel et al. 2011) , Human Protein Reference Database (Keshava Prasad et al. 2009 ), PhosphoNetworks (Newman et al. 2013) , and PhosphoSitePlus (Hornbeck et al. 2012) . After data cleaning based on the above protocols, we obtained 7,346 KSI pairs connecting 2,340 proteins.
Innate Immunity PPIN
As the immune system is frequently involved in cancer, we compiled a specific collection of PPIs among innate immunity-related molecules. The InnateDB (Breuer et al. 2013) deposited more than 18,000 molecular interactions related to innate immunity, providing a comprehensive resource for innate immunity component molecules as well as their networks and biological pathways. After removing duplicated or self-loop pairs, we obtained 6,009 unique innate immunityrelated PPI pairs connecting 2,787 proteins.
Computationally Predicted PPIN
We downloaded the PPIs based on computational predictions from HumanNet (v1.0) (Lee et al. 2011 ). HumanNet applied a naïve Bayes approach to assign a score to each PPI by combining multiple lines of evidence in four organisms (human, yeast, worn, and fly). After removing duplicated or self-loop pairs, CPPIN included 474,017 unique PPI pairs connecting 16,166 proteins.
Microarray Gene Expression Data and Coexpression Analysis
The gene coexpression correlation was measured using a microarray expression study of 126 normal tissues (Benita et al. 2010) . The quantile normalization was used to normalize the expression values at the probe level. We then computed the PCC based on the normalized values. It takes two genes to derive a PCC value although each gene has its own connectivity value. However, for a gene, say gene i, we can calculate the avePCC using ð Þ i ¼ P j PCC ij between gene i and gene j (j belongs to the set of gene i's interacting partners in PPIN), based on a previous work (Goh et al. 2007) . For a gene, we can then compute the correlation between its connectivity and its average correlation coefficient.
Somatic Mutations of the Cancer Genome
Somatic mutations identified from 3,268 tumors across 12 cancer types in TCGA were downloaded from the supplementary data in a previous work (Kandoth et al. 2013 ). These 12 cancer types are lung adenocarcinoma, lung squamous cell carcinoma, breast adenocarcinoma, uterine corpus endometrial carcinoma, bladder urothelial carcinoma, colon and rectal carcinoma cancer, acute myeloid leukemia, serous ovarian carcinoma, glioblastoma multiforme, kidney renal clear cell carcinoma, and head and neck squamous cell carcinoma. We obtained 450,838 somatic mutations: 433,117 nonsynonymous single-nucleotide variants and 17,721 short indels in 18,242 gene-coding regions; and 129,150 silent somatic mutations in 17,337 genes. In addition, we collected 848,455 nonsynonymous single nucleotide variants and short indels in 19,626 genes from the COSMIC (Forbes et al. 2011) . As one mutation might occur in multiple samples in more than one subtype of cancer, we counted the mutations with the same MutationID as one event.
Computing Selective Pressure and Evolutionary Rate
We calculated the dN/dS ratio (Hirsh et al. 2005) to examine the selective pressure on a gene. First, we used human-mouse orthologous genes to calculate the dN and dS substitution rates. In total, 16,854 genes are available using the humanmouse sequence data from the Ensemble BioMart database (http://useast.ensembl.org/biomart/martview/8fb62cdeefcf42 871a78638 6d492fbb3, last accessed July 1, 2013). Second, we calculated the evolutionary rate ratio using the MatrixMatchMaker method (Tillier and Charlebois 2009; Clark et al. 2011; Bezginov et al. 2013) . In total, the 20,804 Orthologous MAtrix (OMA) groups containing human proteins collected from the OMA browser (Altenhoff et al. 2011) were used as the input data for the evolutionary rate ratio calculation. Only eukaryotic orthologs (from 103 genomes) were used. The detailed calculation procedure was described in Clark et al. (2011) and Bezginov et al. (2013) .
Inferring Protein Evolutionary Origin
The evolutionary origin of a protein refers to the date that the protein originated and can be inferred from phylogenetic analysis. We used the protein origin data from ProteinHistorian (Capra et al. 2012) . Specially, the origin (age) of a protein was estimated by considering three factors: A species tree, a protein family database, and an ancestral family reconstruction algorithm. Furthermore, the evolutionary distance was calculated based on the comparison of human sequences with their orthologous groups in other animals, using a published method (Bezginov et al. 2013 ).
Network Analysis and Statistical Tests
The connectivity of a protein in a network (i.e., degree) was defined as the number of the edges directly linking the protein. We calculated protein connectivity using the software Cytoscape (v3.0) (Shannon et al. 2003) . "Hub" proteins are defined as those nodes that are ranked at the top 20% of the connectivity distribution (Yu et al. 2007; Zhang et al. 2011 ). In addition, we evaluated network features by defining the "hub" proteins as being ranked at the top 5% and 10% of the connectivity distribution. The network and topological parameters were visualized by Cytoscape (v3.0) (Shannon et al. 2003) . The GO biological process and KEGG pathway enrichment analyses were carried out using ClueGO (Bindea et al. 2009 ). The hypergeometric test was performed to detect pathways significantly enriched with genes in testing. All statistical tests were performed using the R package (v3.0.1, http://www.rproject.org/, last accessed July 1, 2013).
Supplementary Material
Supplementary figures S1-S11 and tables S1-S18 are available at Molecular Biology and Evolution online (http://www.mbe. oxfordjournals.org/).
